These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2689424)

  • 21. Glucan synthesis and its inhibition by cilofungin in susceptible and resistant strains of Candida albicans.
    Angiolella L; Bromuro C; Simonetti N; Cassone A
    J Med Vet Mycol; 1992; 30(5):369-76. PubMed ID: 1469538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. pH and other effects on the antifungal activity of cilofungin (LY121019).
    McIntyre KA; Galgiani JN
    Antimicrob Agents Chemother; 1989 May; 33(5):731-5. PubMed ID: 2751286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinal toxicity and in vitro efficacy study of cilofungin (LY121019).
    Shahsavari M; Peyman GA; Niesman MR
    Ophthalmic Surg; 1990 Oct; 21(10):726-8. PubMed ID: 2250858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of amorolfine (Ro 14-4767/002) on in vitro phagocytosis and intracellular killing of Candida albicans by human neutrophils.
    Richardson MD; Shankland GS; Gray CA
    Mycoses; 1989 May; 32(5):245-9. PubMed ID: 2668755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agar disk diffusion susceptibility tests with cilofungin (LY 121019).
    Espinel-Ingroff A; Shadomy S; White S
    J Med Vet Mycol; 1991; 29(2):93-8. PubMed ID: 1880684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) against Aspergillus and Candida species.
    Huang A; Edwards F; Bernard EM; Armstrong D; Schmitt HJ
    Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):697-9. PubMed ID: 2226501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.
    Bartizal K; Abruzzo G; Trainor C; Krupa D; Nollstadt K; Schmatz D; Schwartz R; Hammond M; Balkovec J; Vanmiddlesworth F
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1648-57. PubMed ID: 1416847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis.
    Walsh TJ; Lee JW; Kelly P; Bacher J; Lecciones J; Thomas V; Lyman C; Coleman D; Gordee R; Pizzo PA
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1321-8. PubMed ID: 1929288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in vitro activity of LY121019 and amphotericin B against clinical isolates of Candida species.
    Spitzer ED; Travis SJ; Kobayashi GS
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):80-1. PubMed ID: 3132386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of cilofungin (LY121019) against Candida species in vitro.
    Odds FC
    J Antimicrob Chemother; 1988 Dec; 22(6):891-7. PubMed ID: 3243737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo anti-Candida activity and toxicology of LY121019.
    Gordee RS; Zeckner DJ; Ellis LF; Thakkar AL; Howard LC
    J Antibiot (Tokyo); 1984 Sep; 37(9):1054-65. PubMed ID: 6389460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Candida activity and toxicology of LY121019, a novel semisynthetic polypeptide antifungal antibiotic.
    Gordee RS; Zeckner DJ; Howard LC; Alborn WE; Debono M
    Ann N Y Acad Sci; 1988; 544():294-309. PubMed ID: 3063174
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of cilofungin as direct fluorescent probe for monitoring antifungal drug-membrane interaction.
    Ko YT; Ludescher RD; Frost DJ; Wasserman BP
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1378-85. PubMed ID: 8092841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of the antifungal activity of LY121019, a new echinocandin derivative.
    Strippoli V; D'Auria FD; Simonetti N
    Chemioterapia; 1988 Feb; 7(1):33-7. PubMed ID: 3288366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of LY121019, a member of a series of semisynthetic analogues of the antifungal lipopeptide echinocandin B.
    Debono M; Abbott BJ; Turner JR; Howard LC; Gordee RS; Hunt AS; Barnhart M; Molloy RM; Willard KE; Fukuda D
    Ann N Y Acad Sci; 1988; 544():152-67. PubMed ID: 3063167
    [No Abstract]   [Full Text] [Related]  

  • 36. Synergy between cilofungin and amphotericin B in a murine model of candidiasis.
    Hanson LH; Perlman AM; Clemons KV; Stevens DA
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1334-7. PubMed ID: 1929290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The activity of cilofungin on the incorporation of glucan associated proteins into hyphal cells of Candida albicans.
    Angiolella L; Facchin M; Simonetti N; Cassone A
    J Chemother; 1995 Apr; 7(2):83-9. PubMed ID: 7666125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis.
    Morrison CJ; Stevens DA
    Antimicrob Agents Chemother; 1990 May; 34(5):746-50. PubMed ID: 2193617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of caspofungin (MK-0991) and anidulafungin (LY303366) on phagocytosis, oxidative burst and killing of Candida albicans by human phagocytes.
    Frank U; Greiner M; Engels I; Daschner FD
    Eur J Clin Microbiol Infect Dis; 2004 Sep; 23(9):729-31. PubMed ID: 15300456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations.
    Stevens DA; Espiritu M; Parmar R
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3407-11. PubMed ID: 15328104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.